Insight

Optimizing N-(2,6-Dimethylphenyl)-2-(Piperazin-1-Yl)Acetamide

Scaling Ranolazine Intermediate production often faces yield losses due to piperazine double-substitution and unsafe solvent recovery during the synthesis route.

Troubleshooting common impurities and yield issues

Minimizing Piperazine Double-Substitution

Traditional methods using excess anhydrous piperazine often generate disubstituted byproducts. Optimizing molar ratios of piperazine salts ensures high industrial purity while simplifying post-processing.

Solvent Safety and Recovery Efficiency

Replacing volatile ethers with aqueous or ethanol-based systems reduces explosion risks. NINGBO INNO PHARMCHEM CO.,LTD. prioritizes safe protocols to mitigate these hazards.

For detailed specifications on this chemical building block, view our N-(2,6-Dimethylphenyl)-2-piperazin-1-ylacetamide product page.

Technical specifications and analytical methods

ParameterSpecification
CAS Number5294-61-1
Purity (HPLC)>99.5%
AppearanceOff-white Granular Solid
DocumentationBatch-specific COA

Industrial packaging options and global logistics handling

We supply this material in 25kg fiber drums or IBCs for large-scale needs. Our logistics network ensures a stable supply chain to major pharmaceutical hubs worldwide.

NINGBO INNO PHARMCHEM CO.,LTD. remains committed to quality and reliability for all R&D and procurement partners.

To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.